These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31134511)

  • 1. Clinical significance of epithelial-mesenchymal transition-related markers expression in the micrometastatic sentinel lymph node of NSCLC.
    Lafuente-Sanchis A; Olmo A; Carretero J; Alcacer Fernandez-Coronado J; Estors-Guerrero M; Martínez-Hernández NJ; Cremades A; Zúñiga A; Alcacer J; Farras R; Cuenca M; Galbis-Caravajal JM
    Clin Transl Oncol; 2020 Mar; 22(3):381-391. PubMed ID: 31134511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated vimentin and upregulated E-cadherin in T1 stage non-small-cell lung cancer: does it suggest a mesenchymal-epithelial transition?
    Luo T; Wang L; Wu P; Gong W; Chen W; Zhao H; Zheng Z
    Neoplasma; 2017; 64(5):693-699. PubMed ID: 28592120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
    Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
    Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
    Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of micrometastases and its clinical significance in sentinel and non-sentinel lymph nodes from early cervical carcinoma].
    Lou HM; Zhu T; Shao F; Yang ZY; Fang XH; Feng JG
    Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):434-8. PubMed ID: 24119903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of detection of sentinel lymph nodes on lymphatic metastasis of non-small cell lung cancer].
    Zhu ZH; Li BJ; Zhang SY; Rong TH; Zeng CG; Yu H; Hu Y; Zhang X; Fu JH; Long H; Lin P; Wang SY; Wang X; Yang MT; Huang ZF
    Ai Zheng; 2005 Mar; 24(3):341-4. PubMed ID: 15757538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours.
    Chen B; Zhang G; Lai J; Xiao W; Li X; Li C; Mok H; Li K; Wang Y; Cao L; Jia M; Ren C; Wen L; Wei G; Lin J; Li Y; Zhang Y; Chen X; Wu X; Zhang H; Li M; Liu J; Balch CM; Liao N
    EBioMedicine; 2021 Sep; 71():103542. PubMed ID: 34454403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Ma T; Zhao Y; Wei K; Yao G; Pan C; Liu B; Xia Y; He Z; Qi X; Li Z; Wang J; Shao Y
    Cell Physiol Biochem; 2016; 38(4):1563-74. PubMed ID: 27073840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.
    Umekita Y; Ohi Y; Iwaya O; Souda M; Sagara Y; Tamada S; Yotsumoto D; Tanimoto A
    Histopathology; 2018 Dec; 73(6):916-922. PubMed ID: 30035819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node in lung cancer surgery.
    Melfi FM; Davini F; Boni G; Mussi A
    Thorac Surg Clin; 2012 May; 22(2):205-14. PubMed ID: 22520287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.
    Shimamatsu S; Okamoto T; Haro A; Kitahara H; Kohno M; Morodomi Y; Tagawa T; Okano S; Oda Y; Maehara Y
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1012-1020. PubMed ID: 27600618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
    Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients.
    Emprou C; Le Van Quyen P; Jégu J; Prim N; Weingertner N; Guérin E; Pencreach E; Legrain M; Voegeli AC; Leduc C; Mennecier B; Falcoz PE; Olland A; Santelmo N; Quoix E; Massard G; Guenot D; Chenard MP; Beau-Faller M
    Cancer Med; 2018 Jul; 7(7):3278-3291. PubMed ID: 29845746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.